focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Advisory Board Appointment - Juan Villalonga

6 Jan 2011 07:05

RNS Number : 9859Y
Phorm Inc
05 January 2011
 



Phorm, Inc.

Advisory Board Appointment

6 January 2011

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE

UNITED STATES, CANADA, JAPAN OR AUSTRALIA

 

Phorm, Inc.

('Phorm' or the 'Company')

 

Advisory Board Appointment - Juan Villalonga

 

Phorm (AIM: PHRM and PHRX), the internet personalisation technology company, is pleased to announce the creation of an Advisory Board whose mandate will be to advise the board and management team on major aspects of the Company's business, in particular the adoption and deployment of the Company's technology with ISPs around the world.

 

The Company is also delighted to announce the appointment of Juan Villalonga as Chairman of the Company's Advisory Board. Further appointments will be made in due course.

 

As CEO of Telefónica S.A. from 1996-2000, Mr Villalonga oversaw an increase in the company's market capitalisation of $127 billion, in the process turning Telefónica into one of the top three telecommunications companies in the world.

 

Kent Ertugrul, Phorm's CEO said, "Juan Villalonga is a giant of the Telecommunications industry and we are delighted to welcome someone of his stature as Chairman of our Advisory Board. Following our successful launch in Brazil we have seen a significant increase in the level of interest from ISPs around the world and we look forward to working with Mr Villalonga to help us exploit these opportunities as we move to the next stage in our development."

 

Juan Villalonga has held a number of prominent positions in his career. In addition to his position within Telefónica S.A., he was a partner at McKinsey & Company (1980-1989), CEO for Credit Suisse First Boston in Spain (1993-1994), and CEO of Bankers' Trust in Spain (1995-1996). In 2010, Harvard Business Review named Mr. Villalonga one of the world's 100 best performing CEOs.

 

Juan Villalonga commented, "I am deeply impressed by the Company's team and technology. I believe that Phorm's proposition to consumers and the industry alike reflects the next stage in the evolution of the internet. By offering consumers an explicit choice and protecting the privacy of participants to an unprecedented degree, Phorm has managed to address one of the industry's big problems and provide a business model to support the next generation of internet services."

 

Enquiries:

 

Phorm, Inc.

Andy Croxson (analysts & investors) +44 20 7297 2326

Alex Laity (media) +44 20 7297 2710

 

Canaccord Genuity Limited +44 20 7050 6500

(Nominated Advisor)

Mark Williams

Andrew Chubb

 

About Phorm:

Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience. Phorm's partners include leading ISPs, Publishers, Ad Networks and Advertisers.

 

Phorm is a Delaware, US incorporated company, with offices in Seoul, Moscow, Sao Paulo and London. The Company was admitted to the AIM market of the London Stock Exchange in 2004 and has over 150 employees and direct contractors. For more information, please visit: www.phorm.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSSEFWIFFSEFF
Date   Source Headline
22nd Feb 20088:25 amRNSStockholder Meeting
14th Feb 20087:01 amRNSISP agreements
1st Feb 20088:55 amRNSExercise of Options
28th Jan 20087:01 amRNSTransfer of Shares
15th Jan 20087:00 amRNSManagement Appointment
11th Jan 20085:01 pmRNSExercise of Options
20th Dec 20075:47 pmRNSDirector/PDMR Shareholding
17th Dec 20071:56 pmRNSExercise of Options
30th Nov 20075:32 pmRNSHolding(s) in Company
7th Nov 20072:06 pmRNSExercise of Options
1st Oct 20077:02 amRNSDirectorate Change
28th Sep 20078:02 amRNSInterim Results
12th Sep 20079:33 amRNSHolding(s) in Company
20th Aug 20077:00 amRNSAIM Rule 26
27th Jul 20073:27 pmRNSDirector/PDMR Shareholding
17th Jul 200710:03 amRNSDirector Change - Replacement
17th Jul 20079:12 amRNSDirectorate Change
13th Jul 20071:26 pmRNSExercise of options
18th Jun 20074:50 pmRNSNotification of Interest
18th Jun 20077:01 amRNSAdditional Listing
15th Jun 20077:58 amRNSStmnt re Share Price Movement
6th Jun 20074:11 pmRNSHolding(s) in Company
21st May 20077:02 amRNSDirectorate Change
16th May 20074:17 pmRNSIssue of Equity
4th May 20077:00 amRNSRe-Organisation
3rd May 20077:01 amRNSRe-Organisation
2nd May 20072:01 pmRNSPress speculation
1st May 20078:20 amRNSSch 1 Update - Phorm, Inc.
27th Apr 20074:27 pmRNSSch 1 Update - Phorm, Inc.
26th Apr 200711:52 amRNSNotification of Holding
26th Apr 200711:24 amRNSResult of AGM
24th Apr 20077:02 amRNSAnnual Results
12th Apr 20073:45 pmRNSExercise of Options
2nd Apr 200711:02 amRNSSchedule 1 - Phorm, Inc
2nd Apr 20077:02 amRNSNotice of AGM
8th Mar 20077:04 amRNSDirectorate Change
27th Feb 20077:04 amRNSIssue of Equity
1st Feb 200712:40 pmRNSHolding(s) in Company
21st Dec 20063:33 pmPRNTotal Voting Rights
6th Dec 200612:21 pmPRNAdditional Listing
3rd Nov 20063:05 pmPRNStatement re Share Price Movement
18th Aug 200610:45 amPRNAdditional Listing
28th Jul 20067:00 amPRNAdditional Listing
25th Jul 200612:00 pmPRN121Media appoints David Dorman as Adviser
25th Jul 200610:45 amPRNShare Incentive Plan
21st Jul 20067:00 amPRNUpdate on Trading in and settlement of common shares
20th Jul 20067:00 amPRNDirector/PDMR Shareholding
19th Jul 20067:00 amPRNUpdate re: ISP Partnership Strategy
23rd Jun 20064:12 pmPRNFormal Notice
16th Jun 20067:00 amPRNAppointment of EVP Operations

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.